Angelo Rosolen

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, CNS Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations

Most-Cited Works

• → Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead(2015)282 cited
• → Revised International Pediatric Non-Hodgkin Lymphoma Staging System(2015)230 cited
• → Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group(2009)218 cited
• → Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial(2010)197 cited
• → Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial(2018)182 cited
• → Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application(2006)150 cited
• Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.(2002)
• → Primitive Myxoid Mesenchymal Tumor of Infancy(2006)101 cited
• → Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma(2017)97 cited
• → microRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas(2014)95 cited